V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280009415 | 280006685 | 1.6 | 61.9 | Palliative (P) | 2014-09-10 | 2014-09-11 | IPILIMUMAB + NIVOLUMAB | null | null | 280021930 | CISPLATIN + FLUOROURACIL + RT |
| 280009416 | 280006685 | 1.71 | 92.3 | Palliative (P) | null | 2015-09-26 | Eribulin | 01 | N | 280021930 | BCG |
| 280009417 | 280009471 | null | null | Curative (C) | 2014-04-01 | 2014-04-18 | Capecitabine | N | null | 280021985 | CAPECITABINE + CISPLATIN |
| 280009418 | 280006687 | 1.81 | 51.5 | Curative (C) | 2017-12-03 | 2017-12-11 | VDC | N | N | 280022096 | IVADO |
| 280009419 | 280006688 | 1.85 | 80.95 | Palliative (P) | 2016-11-20 | 2016-12-04 | CHOP R - 21 days | N | N | 280022132 | DABRAFENIB + TRAMETINIB |
| 280009420 | 280006689 | 1.6 | 79 | Palliative (P) | 2016-10-16 | 2016-11-22 | DARS Trial | 2 | N | 280022198 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009421 | 280006689 | 1.72 | null | Palliative (P) | 2017-04-28 | 2017-04-28 | Pazopanib | N | N | 280022198 | IRINOTECAN + VINCRISTINE |
| 280009422 | 280006690 | 1.5 | 79.25 | Neo-adjuvant (N) | 2015-07-25 | 2015-07-29 | Capecitabine + Oxaliplatin 21day | 02 | N | 280022483 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009423 | 280006693 | 1.76 | 76.4 | null | 2014-12-10 | 2015-01-11 | Cisplatin + Fluorouracil + RT 5day | null | null | 280022500 | CISPLATIN + DOCETAXEL |
| 280009424 | 280006694 | 1.95 | 60.6 | Palliative (P) | 2015-07-30 | 2015-08-26 | Cyclophosphamide PO +Vinorelbine IV | 02 | N | 280022533 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280009425 | 280006695 | null | 51.3 | Palliative (P) | 2015-05-08 | 2015-06-10 | CISPLATIN + FLUOROURACIL + RT | 2 | N | 280022533 | CARBO + FLUOROURACIL |
| 280009426 | 280006695 | 1.72 | 98 | null | null | 2015-05-01 | IDELALISIB | null | null | 280022533 | PEMBROLIZUMAB |
| 280009427 | 280006696 | 1.77 | null | Curative (C) | 2015-05-19 | 2015-06-26 | MELPHALAN | N | Y | 280022665 | VIA |
| 280009428 | 280006697 | 1.82 | 78.6 | Adjuvant (A) | 2015-01-25 | 2015-02-09 | Cyclophosphamide + Vincristine | N | N | 280022678 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 280009429 | 280009475 | 0 | null | Palliative (P) | 2016-02-03 | 2016-02-03 | TRASTUZUMAB | N | null | 280022719 | CASPS TRIAL |
| 280009430 | 280006698 | null | 61.6 | Palliative (P) | 2019-02-07 | 2019-02-11 | ETOPOSIDE | 02 | N | 280022764 | VIDE |
| 280009431 | 280006698 | 1.62 | 51.9 | Palliative (P) | 2017-12-23 | 2017-12-30 | CETUXIMAB + OXALIPLATIN + MDG | N | Y | 280022764 | GEDDIS TRIAL |
| 280009432 | 280006701 | 1.89 | null | null | 2014-12-30 | 2015-01-05 | Hydroxycarbamide | N | N | 280022848 | BCG |
| 280009433 | 280006701 | 1.7 | null | Palliative (P) | 2018-05-09 | 2018-06-23 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 280022848 | IRINOTECAN + VINCRISTINE |
| 280009434 | 280006702 | null | null | null | 2018-05-18 | 2018-05-31 | Bevacizumab + Cape + Oxali 14day | N | N | 280022899 | LIPOSOMAL DOXORUBICIN |
| 280009435 | 280006703 | 1.64 | 76.3 | Palliative (P) | 2012-10-30 | 2014-04-03 | VINCRISTINE | 02 | N | 280022951 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009436 | 280010822 | null | 55 | Palliative (P) | 2016-06-14 | 2016-06-25 | CMV | 02 | N | 280022962 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009437 | 280010822 | 1.68 | 91 | Neo-adjuvant (N) | 2018-06-12 | 2018-07-06 | Cisplatin + Fluorouracil + RT 5day | N | null | 280022962 | CAPECITABINE + OXALIPLATIN |
| 280009438 | 280010822 | 1.81 | 92.7 | Palliative (P) | 2015-02-11 | 2015-02-16 | Carbo F | N | N | 280022962 | VINCRISTINE |
| 280009439 | 280006706 | 1.78 | 87 | Adjuvant (A) | 2016-02-23 | 2016-02-26 | CASPS TRIAL | N | N | 280023080 | GEFITINIB |
| 280009440 | 280006707 | null | null | Curative (C) | 2018-02-26 | 2018-03-07 | VIDE | null | null | 280023085 | GEMCARBO |
| 280009441 | 280006707 | null | 68 | Palliative (P) | 2017-03-04 | 2017-03-13 | BCG Intravesical | N | N | 280023085 | CAPECITABINE |
| 280009442 | 280006707 | 1.73 | 88.1 | Palliative (P) | 2014-09-14 | 2014-09-15 | Cyclophosphamide + Vincristine | null | null | 280023085 | METHOTREXATE |
| 280009443 | 280006708 | 1.56 | 74.4 | Curative (C) | 2018-03-27 | 2018-04-08 | Cyclophosphamide High Dose | N | null | 280023135 | ETOPOSIDE |
| 280009444 | 280006708 | 1.8 | null | Palliative (P) | 2018-02-07 | 2018-03-10 | BUSULFAN + MELPHALAN | N | N | 280023135 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE |
| 280009445 | 280006710 | 1.72 | 89.8 | Palliative (P) | 2018-10-09 | 2018-10-09 | IDELALISIB | 2 | N | 280023187 | NIVOLUMAB |
| 280009446 | 280006710 | 1.59 | 46.3 | Curative (C) | 2015-02-04 | 2015-03-11 | Carbo F | N | null | 280023187 | VINCRISTINE |
| 280009447 | 280006715 | 1.67 | null | Palliative (P) | 2018-04-02 | 2018-04-09 | CAPECITABINE + IRINOTECAN | N | N | 280023280 | CETUXIMAB + IRINOTECAN |
| 280009448 | 280006717 | 1.68 | 92 | Palliative (P) | 2019-02-16 | 2019-02-17 | CAPECITABINE + TEMOZOLOMIDE | N | N | 280023299 | CISPLATIN + FLUOROURACIL + RT |
| 280009449 | 280006719 | 1.61 | 71.4 | Palliative (P) | 2016-08-10 | 2016-08-24 | Cyclophosphamide + Topotecan | 02 | null | 280023320 | CISPLATIN + DOXORUBICIN |
| 280009450 | 280006721 | 1.6 | null | Palliative (P) | 2017-01-26 | 2017-02-02 | Etoposide + Ifosfamide + HD Mtx | N | N | 280023366 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280009451 | 280006721 | 1.7 | 84.5 | Palliative (P) | 2016-09-21 | 2016-12-17 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 280023366 | VIDE |
| 280009452 | 280006722 | 1.81 | 93 | Curative (C) | 2018-07-23 | 2018-08-13 | Cisplatin + Fluorouracil + RT 5day | N | N | 280023443 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280009453 | 280009491 | 1.5 | 12.6 | Palliative (P) | null | 2017-10-18 | DARS Trial | N | N | 280023443 | CISPLATIN + DOCETAXEL |
| 280009454 | 280009491 | 1.83 | 78.6 | Palliative (P) | 2018-04-07 | 2018-04-07 | GemCarbo Days 1+8 | 2 | N | 280023443 | CAPECITABINE + CISPLATIN |
| 280009455 | 280009491 | 1.62 | null | Palliative (P) | 2017-09-06 | 2017-09-16 | VIA (Ifos 1.5g/m2) | N | N | 280023443 | PEMBROLIZUMAB |
| 280009456 | 280006724 | 1.63 | 62 | null | 2017-12-30 | 2018-02-14 | Carboplatin + Vinorelbine IV | N | N | 280024160 | CARBOPLATIN + CETUXIMAB + FU |
| 280009457 | 280006728 | 1.65 | 68.8 | Palliative (P) | 2018-01-06 | 2018-04-08 | GEMCARBO | 2 | N | 280024195 | CARBO + FLUOROURACIL |
| 280009458 | 280009492 | 2 | null | Curative (C) | 2017-11-06 | 2017-11-06 | GemCarbo Days 1+8 | N | N | 280024777 | IFOSFAMIDE + VINCRISTINE |
| 280009459 | 280006730 | 1.88 | 62 | Curative (C) | 2017-09-17 | 2017-11-19 | Pertuzumab + Trastuzumab IV | 99 | N | 280024898 | VIDE |
| 280009460 | 280006731 | 1.7 | null | Palliative (P) | 2018-08-07 | 2018-08-07 | CARBOPLATIN + FLUOROURACIL | 02 | N | 280024898 | PEMETREXED |
| 280009461 | 280006732 | 1.56 | null | Palliative (P) | 2016-12-24 | 2017-01-28 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 02 | null | 280025184 | CARBO + FLUOROURACIL |
| 280009462 | 280006732 | null | null | Curative (C) | null | 2018-02-07 | AFLIBERCEPT + FU + IRINOTECAN | null | null | 280025184 | VDC |
| 280009463 | 280006735 | 1.7 | 51.7 | Palliative (P) | null | 2018-08-07 | Bortezomib +/- Dexamethasone | 02 | N | 280025750 | DOCETAXEL |
| 280009464 | 280006736 | 1.65 | null | Adjuvant (A) | 2013-06-06 | 2013-06-06 | Cisplatin + Dacarbazine | 02 | N | 280025821 | VDC |